PHGE
BiomX Inc.Company with tickers: PHGE
CIK
1739174
CUSIP
09090D509
Shares Outstanding
6,543,516
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-17 | Yeganeh Reuven | Director | Sell | 530,000 |
| 2026-03-17 | Yeganeh Reuven | Director | Other | 530,000 |
| 2026-03-17 | Yeganeh Reuven | Director | Other | 1,060 |
| 2026-03-16 | Yeganeh Reuven | Director | Sell | 450,000 |
| 2026-03-16 | Yeganeh Reuven | Director | Other | 900 |
| 2026-03-16 | Yeganeh Reuven | Director | Other | 450,000 |
| 2026-03-16 | Yeganeh Reuven | Director | Sell | 1,300,000 |
| 2026-03-13 | Yeganeh Reuven | Director | Sell | 370,000 |
| 2026-03-13 | Yeganeh Reuven | Director | Other | 740 |
| 2026-03-13 | Yeganeh Reuven | Director | Other | 370,000 |
| 2026-03-12 | Yeganeh Reuven | Director | Other | 600 |
| 2026-03-12 | Yeganeh Reuven | Director | Sell | 300,000 |
| 2026-03-11 | Yeganeh Reuven | Director | Other | 300,000 |
| 2026-02-13 | Bidas Liat Cohavi | Director | Other | 0 |
| 2026-01-13 | Yeganeh Reuven | Director | Other | 0 |
| 2026-01-13 | Yeganeh Reuven | Director | Other | 0 |
| 2025-04-21 | Flynn James E | 10% Owner | Award | 1,611,864 |
| 2025-04-14 | Flynn James E | 10% Owner | Award | 17,600 |
| 2025-04-14 | Wolfson Marina | Chief Financial Officer | Award | 95,000 |
| 2025-04-14 | Wolfson Marina | Chief Financial Officer | Award | 68,545 |
| 2025-04-14 | Greig Russell | Director | Award | 35,200 |
| 2025-04-14 | Merril Gregory Louis | Director | Award | 17,600 |
| 2025-04-14 | LEFF JONATHAN S | Director | Award | 17,600 |
| 2025-04-14 | GOODMAN JESSE | Director | Award | 17,600 |
| 2025-04-14 | Bassan Merav | Chief Development Officer | Award | 79,597 |
| 2025-04-14 | Bassan Merav | Chief Development Officer | Award | 95,000 |
| 2025-04-14 | Williams Eddie | Director | Award | 17,600 |
| 2025-04-14 | Moses Alan Charles | Director | Award | 17,600 |
| 2025-04-14 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Award | 380,500 |
| 2025-04-14 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Award | 126,748 |
| 2025-04-14 | Blum Susan | Chief Financial Officer | Award | 17,600 |
| 2025-02-27 | Flynn James E | 10% Owner | Convert | 1,611,863 |
| 2025-02-27 | Flynn James E | 10% Owner | Convert | 353,249 |
| 2025-02-27 | Flynn James E | 10% Owner | Award | 1,258,614 |
| 2025-02-26 | Cystic Fibrosis Foundation | 10% Owner | Other | 0 |
| 2024-09-16 | Bassan Merav | Chief Development Officer | Award | 31,749 |
| 2024-09-16 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Award | 50,556 |
| 2024-09-16 | Oron Assaf | Chief Business Officer | Award | 25,804 |
| 2024-07-15 | Flynn James E | 10% Owner | Convert | 5,883,000 |
| 2024-07-15 | Flynn James E | 10% Owner | Convert | 5,883 |
| 2024-07-11 | Flynn James E | 10% Owner | Award | 264,000 |
| 2024-07-11 | Blum Susan | Chief Financial Officer | Award | 264,000 |
| 2024-07-11 | Greig Russell | Director | Award | 352,000 |
| 2024-07-11 | Bassan Merav | Chief Development Officer | Award | 950,000 |
| 2024-07-11 | Wolfson Marina | Chief Financial Officer | Award | 950,000 |
| 2024-07-11 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Award | 3,805,000 |
| 2024-07-11 | LEFF JONATHAN S | Director | Award | 264,000 |
| 2024-07-11 | GOODMAN JESSE | Director | Award | 264,000 |
| 2024-07-11 | Merril Gregory Louis | Director | Award | 264,000 |
| 2024-07-11 | Williams Eddie | Director | Award | 176,000 |
| 2024-07-11 | Oron Assaf | Chief Business Officer | Award | 237,500 |
| 2024-07-11 | Moses Alan Charles | Director | Award | 176,000 |
| 2024-07-09 | Flynn James E | 10% Owner | Award | 722,175 |
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Exercise | 9,280,408 |
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | 24,344 |
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Exercise | 9,280,408 |
| 2024-05-15 | Cystic Fibrosis Foundation | 10% Owner | Exercise | 4,778,265 |
| 2024-05-15 | Cystic Fibrosis Foundation | 10% Owner | Exercise | 4,778,265 |
| 2024-04-11 | Blum Susan | Chief Financial Officer | Other | 0 |
| 2024-03-16 | Cystic Fibrosis Foundation | 10% Owner | Other | 4,552,315 |
| 2024-03-16 | Cystic Fibrosis Foundation | 10% Owner | Other | 0 |
| 2024-03-16 | Cystic Fibrosis Foundation | 10% Owner | Other | 0 |
| 2024-03-15 | Flynn James E | 10% Owner | Award | 13,490 |
| 2024-03-15 | Flynn James E | 10% Owner | Award | 3,055,049 |
| 2024-03-15 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Buy | 4,327 |
| 2024-03-15 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Buy | 2,163,500 |
| 2024-03-15 | Merril Gregory Louis | Director | Other | 0 |
| 2024-03-15 | GOODMAN JESSE | Director | Other | 0 |
| 2024-03-15 | Flynn James E | 10% Owner | Other | 0 |
| 2024-03-15 | LEFF JONATHAN S | Director | Other | 0 |
| 2023-12-11 | Wolfson Marina | Chief Financial Officer | Other | 36,000 |
| 2023-12-11 | Wolfson Marina | Chief Financial Officer | Award | 9,474 |
| 2023-12-11 | Bassan Merav | Chief Development Officer | Award | 12,500 |
| 2023-12-11 | Bassan Merav | Chief Development Officer | Other | 47,500 |
| 2023-12-11 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Other | 144,000 |
| 2023-12-11 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Award | 37,895 |
| 2023-12-11 | Oron Assaf | Chief Business Officer | Award | 8,290 |
| 2023-12-11 | Oron Assaf | Chief Business Officer | Other | 31,500 |
| 2023-12-06 | Gabay Avraham | Chief Financial Officer | Other | 0 |
| 2023-11-29 | Oron Assaf | Chief Business Officer | Sell | 5,444 |
| 2023-10-29 | Bassan Merav | Chief Development Officer | Award | 189,997 |
| 2023-10-29 | Bassan Merav | Chief Development Officer | Other | 189,997 |
| 2023-10-29 | Wolfson Marina | Chief Financial Officer | Award | 59,800 |
| 2023-10-29 | Oron Assaf | Chief Business Officer | Award | 155,363 |
| 2023-10-29 | Oron Assaf | Chief Business Officer | Other | 155,363 |
| 2023-10-29 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Award | 182,133 |
| 2023-10-29 | Solomon Jonathan Eitan | Director, Chief Executive Officer | Other | 182,133 |
| 2023-10-19 | Williams Eddie | Director | Award | 41,000 |
| 2023-10-12 | Williams Eddie | Director | Other | 0 |
| 2023-08-21 | Marks Jason M. | EVP,Chief Global Legal Officer | Award | 41,000 |
| 2023-08-21 | Dambach Michael E. | Director | Award | 41,000 |
| 2023-05-22 | Oron Assaf | Chief Business Officer | Buy | 3,192 |
| 2023-05-19 | Oron Assaf | Chief Business Officer | Buy | 6,521 |
| 2023-05-18 | Oron Assaf | Chief Business Officer | Buy | 1,201 |
| 2023-05-11 | Marks Jason M. | EVP,Chief Global Legal Officer | Other | 0 |
| 2023-05-11 | Dambach Michael E. | Director | Other | 0 |
| 2023-03-01 | Greig Russell | Director | Award | 82,000 |
| 2023-03-01 | Sullivan Lynne Marie | Director | Award | 41,000 |
| 2023-03-01 | Moses Alan Charles | Director | Award | 41,000 |
| 2023-03-01 | Bassan Merav | Chief Development Officer | Award | 100,000 |